Abdominal fat and sarcopenia in women significantly alter osteoblasts homeostasis in vitro by a WNT/ β -catenin dependent mechanism

International Journal of Endocrinology

Volumn 2014, Issue , 2014, Pages

  Wannenes, Francesca ^a   Papa, Vincenza ^a   Greco, Emanuela A ^b   Fornari, Rachele ^b   Marocco, Chiara ^b   Baldari, Carlo ^a   Di Luigi, Luigi ^a   Emerenziani, Gian Pietro ^a   Poggiogalle, Eleonora ^b   Guidetti, Laura ^a   Donini, Lorenzo M ^b   Lenzi, Andrea ^b   Migliaccio, Silvia ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CATENIN; BONE MORPHOGENETIC PROTEIN 4; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; OSTEOPONTIN; WNT PROTEIN;

ABDOMINAL FAT; ADULT; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE DENSITY; BONE TURNOVER; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; GENE TARGETING; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; OBESITY; OSSIFICATION; OSTEOBLAST; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SARCOPENIA; SIGNAL TRANSDUCTION;

EID: 84902156360     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2014/278316     Document Type: Article

References (50)

1. Rossner S., Obesity: the disease of the twenty-first century. International Journal of Obesity and Related Metabolic Disorders 2002 26, supplement 4 S2 S4 (Pubitemid 36071962)
2. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, Osteoporosis prevention, diagnosis, and therapy. The Journal of the American Medical Association 2001 285 6 785 795
3. Felson D. T., Zhang Y., Hannan M. T., Anderson J. J., Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. Journal of Bone and Mineral Research 1993 8 5 567 573 2-s2.0-0027310187 (Pubitemid 23127916)
4. Albala C., Yanez M., Devoto E., Sostin C., Zeballos L., Santos J. L., Obesity as a protective factor for postmenopausal osteoporosis. International Journal of Obesity and Related Metabolic Disorders 1996 20 1027 1032 (Pubitemid 26366457)
5. Ehrlich P. J., Lanyon L. E., Mechanical strain and bone cell function: a review. Osteoporosis International 2002 13 9 688 700 2-s2.0-0036712047 10.1007/s001980200095 (Pubitemid 35000996)
6. Premaor M. O., Pilbrow L., Tonkin C., Parker R. A., Compston J., Obesity and fractures in postmenopausal women. Journal of Bone and Mineral Research 2010 25 2 292 297 2-s2.0-77953369365 10.1359/jbmr.091004
7. Greco E. A., Fornari R., Rossi F., Santiemma V., Prossomariti G., Annoscia C., Aversa A., Brama M., Marini M., Donini L. M., Spera G., Lenzi A., Lubrano C., Migliaccio S., Is obesity protective for osteoporosis? Evaluation of bone mineral density in individuals with high body mass index. International Journal of Clinical Practice 2010 64 6 817 820 2-s2.0-77950655856 10.1111/j.1742-1241.2009.02301.x
8. Kim K.-C., Shin D.-H., Lee S.-Y., Im J.-A., Lee D.-C., Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women. Yonsei Medical Journal 2010 51 6 857 863 2-s2.0-77957941579 10.3349/ymj.2010.51.6.857
9. Cinti S., The adipose organ: endocrine aspects and insights from transgenic models. Eating and Weight Disorders 2001 6, supplement 3 4 8 2-s2.0-0035464415
10. Attie A. D., Scherer P. E., Adipocyte metabolism and obesity. Journal of Lipid Research 2009 50, supplement S395 S399 2-s2.0-66349115342 10.1194/jlr.R800057-JLR200
11. Klein J., Perwitz N., Kraus D., Fasshauer M., Adipose tissue as source and target for novel therapies. Trends in Endocrinology and Metabolism 2006 17 1 26 32 2-s2.0-29744458790 10.1016/j.tem.2005.11.008 (Pubitemid 43031381)
12. Gómez-Ambrosi J., Rodríguez A., Catalán V., Frühbeck G., The bone-adipose axis in obesity and weight loss. Obesity Surgery 2008 18 9 1134 1143 10.1007/s11695-008-9548-1
13. Gimble J. M., Zvonic S., Floyd Z. E., Kassem M., Nuttall M. E., Playing with bone and fat. Journal of Cellular Biochemistry 2006 98 2 251 266 2-s2.0-33646132982 10.1002/jcb.20777
14. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
15. Magni P., Dozio E., Galliera E., Ruscica M., Corsi M. M., Molecular aspects of adipokine-bone interactions. Current Molecular Medicine 2010 10 6 522 532 2-s2.0-77958016364
16. Rolland Y., Czerwinski S., van Kan G. A., Morley J. E., Cesari M., Onder G., Woo J., Baumgartner R., Pillard F., Boirie Y., Chumlea W. M. C., Vellas B., Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. Journal of Nutrition, Health and Aging 2008 12 7 433 450 2-s2.0-50049127614 10.1007/BF02982704
17. Cruz-Jentoft A. J., Baeyens J. P., Bauer J. M., Boirie Y., Cederholm T., Landi F., Martin F. C., Michel J.-P., Rolland Y., Schneider S. M., Topinková E., Vandewoude M., Zamboni M., Sarcopenia: european consensus on definition and diagnosis. Age and Ageing 2010 39 4 412 423 2-s2.0-77953870112 10.1093/ageing/afq034 afq034
18. Migliaccio S., Greco E. A., Fornari R., Donini L. M., Lenzi A., Is obesity in women protective against osteoporosis? Diabetes Metabolic Syndrome and Obesity 2011 4 273 282
19. Zaidi M., Buettner C., Sun L., Iqbal J., Minireview: the link between fat and bone: does mass beget mass? Endocrinology 2012 153 5 2070 2075 2-s2.0-84860340478 10.1210/en.2012-1022
20. Schwetz V., Pieber T., Obermayer-Pietsch B., The endocrine role of the skeleton: background and clinical evidence. European Journal of Endocrinology 2012 166 6 959 967 10.1530/EJE-12-0030
21. Kaptoge S., Kaptoge S., White I. R., Thompson S. G., Wood A. M., Lewington S., Lowe G. D. O., Danesh J., Associations of plasma fibrinogen levels with established cardiovascular disease risk factors, inflammatory markers, and other characteristics: individual participant meta-analysis of 154,211 adults in 31 prospective studies. The American Journal of Epidemiology 2007 166 8 867 879 2-s2.0-34848902631 10.1093/aje/kwm191 (Pubitemid 47511690)
22. Kiefer F. W., Zeyda M., Todoric J., Huber J., Geyeregger R., Weichhart T., Aszmann O., Ludvik B., Silberhumer G. R., Prager G., Stulnig T. M., Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology 2008 149 3 1350 1357 2-s2.0-40849097785 10.1210/en.2007-1312 (Pubitemid 351397930)
23. Wortsman J., Matsuoka L. Y., Chen T. C., Lu Z., Holick M. F., Decreased bioavailability of vitamin D in obesity. The American Journal of Clinical Nutrition 2000 72 3 690 693 2-s2.0-0033847865 (Pubitemid 30667088)
24. Lamendola C. A., Ariel D., Feldman D., Reaven G. M., Relations between obesity, insulin resistance, and 25-hydroxyvitamin D. The American Journal of Clinical Nutrition 2012 95 5 1055 1059 2-s2.0-84860273372 10.3945/ajcn.111. 032060
25. Bray G. A., Contemporary Diagnosis and Management of Obesity 1998 Newton, PA, USA Handbooks in Health Care
26. Norgan N. G., Durnin J. V. G. A., The effect of 6 weeks of overfeeding on the body weight, body composition, and energy metabolism of young men. The American Journal of Clinical Nutrition 1980 33 5 978 988 2-s2.0-0019304735 (Pubitemid 10040629)
27. Greco E. A., Francomano D., Fornari R., Marocco C., Lubrano C., Papa V., Negative association between trunk fat, insuline resistance and skeleton in obese women. World Journal of Diabetes 2013 4 2 31 39 10.4239/wjd.v4.i2.31
28. Migliaccio S., Francomano D., Bruzziches R., Trunk fat negatively influences skeletal and testicular functions in obese men: clinical implications for the aging male. International Journal of Endocrinology 2013 2013 6 182753 10.1155/2013/182753
29. Wannenes F., Caprio M., Gatta L., Fabbri A., Bonini S., Moretti C., Androgen receptor expression during C2C12 skeletal muscle cell line differentiation. Molecular and Cellular Endocrinology 2008 292 1-2 11 19 2-s2.0-49349110946 10.1016/j.mce.2008.05.018
30. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-Δ Δ C t method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
31. Denhardt D. T., Guo X., Osteopontin: a protein with diverse functions. The FESAB Journal 1993 7 15 1475 1482 2-s2.0-0027131418 (Pubitemid 24003267)
32. Sodek J., Chen J., Nagata T., Kasugai S., Todescan R. Jr., Li I. W. S., Kim R. H., Regulation of osteopontin expression in osteoblasts. Annals of the New York Academy of Sciences 1995 760 223 241 2-s2.0-0029111898 10.1111/j.1749-6632.1995.tb44633.x
33. Sodek J., Ganss B., McKee M. D., Osteopontin. Critical Reviews in Oral Biology and Medicine 2000 11 3 279 303 2-s2.0-0033810657
34. Fodor D., Bondor C., Albu A., Simon S. P., Craciun A., Muntean L., The value of osteopontin in the assessment of bone mineral density status in postmenopausal women. Journal of Investigative Medicine 2013 61 1 15 21 10.231/JIM.0b013e3182761264
35. Boudiffa M., Wade-Gueye N. M., Guignandon A., Vanden-Bossche A., Sabido O., Aubin J. E., Jurdic P., Vico L., Lafage-Proust M. H., Malaval L., Bone sialoprotein deficiency impairs osteoclastogenesis and mineral resorption in vitro. Journal of Bone and Mineral Research 2010 25 12 2669 2679 2-s2.0-78649623144 10.1002/jbmr.245
36. Westendorf J. J., Kahler R. A., Schroeder T. M., Wnt signaling in osteoblasts and bone diseases. Gene 2004 341 1-2 19 39 2-s2.0-5044228112 10.1016/j.gene.2004.06.044 (Pubitemid 39335880)
37. Rao T. P., Kühl M., An updated overview on wnt signaling pathways: a prelude for more. Circulation Research 2010 106 12 1798 1806 2-s2.0-77954210220 10.1161/CIRCRESAHA.110.219840
38. MacDonald B. T., Tamai K., He X., Wnt/ β -catenin signaling: components, mechanisms, and diseases. Developmental Cell 2009 17 1 9 26 2-s2.0-67650230896 10.1016/j.devcel.2009.06.016
39. Schmitz Y., Rateitschak K., Wolkenhauer O., Analysing the impact of nucleo-cytoplasmic shuttling of β -catenin and its antagonists APC, Axin and GSK3 on Wnt/ β -catenin signalling. Cell Signal 2013 25 11 2210 2221 10.1016/j.cellsig.2013.07.005
40. Klein K. O., Larmore K. A., de Lancey E., Brown J. M., Considine R. V., Hassink S. G., Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. Journal of Clinical Endocrinology and Metabolism 1998 83 10 3469 3475 2-s2.0-0031741171 10.1210/jc.83.10.3469 (Pubitemid 28500873)
41. Cohen A., Dempster D. W., Recker R. R., Lappe J. M., Zhou H., Zwahlen A., Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. Journal of Clinical Endocrinology and Metabolism 2013 98 6 2562 2572 10.1210/jc.2013-1047
42. Migliaccio S., Wannenes F., Lenzi A., Guidetti L., The molecular and cellular basis of the effects of mechanical load on the musculoskeletal system. Journal of Sports Medicine and Physical Fitness 2013 53 3, supplement 1 1 5
43. Yakar S., Rosen C. J., Beamer W. G., Ackert-Bicknell C. L., Wu Y., Liu J.-L., Ooi G. T., Setser J., Frystyk J., Boisclair Y. R., LeRoith D., Circulating levels of IGF-1 directly regulate bone growth and density. Journal of Clinical Investigation 2002 110 6 771 781 2-s2.0-0036740049 10.1172/JCI200215463
44. Cao J. J., Effects of obesity on bone metabolism. Journal of Orthopaedic Surgery and Research 2011 15 6 30 10.1186/1749-799X-6-30
45. Komori T., Signaling networks in RUNX2-dependent bone development. Journal of Cellular Biochemistry 2011 112 3 750 755 2-s2.0-79951792447 10.1002/jcb.22994
46. Canalis E., Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nature Reviews Endocrinology 2013 9 10 575 583 10.1038/nrendo.2013.154
47. Kahler R. A., Westendorf J. J., Lymphoid enhancer factor-1 and β -catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. The Journal of Biological Chemistry 2003 278 14 11937 11944 2-s2.0-0038485600 10.1074/jbc.M211443200 (Pubitemid 36800167)
48. Kahler R. A., Galindo M., Lian J., Stein G. S., van Wijnen A. J., Westendorf J. J., Lymphocyte enhancer-binding factor 1 (Lef1) inhibits terminal differentiation of osteoblasts. Journal of Cellular Biochemistry 2006 97 5 969 983 2-s2.0-33645243606 10.1002/jcb.20702
49. Hoeppner L. H., Secreto F., Jensen E. D., Li X., Kahler R. A., Westendorf J. J., Runx2 and bone morphogenic protein 2 regulate the expression of an alternative lef1 transcript during osteoblast maturation. Journal of Cellular Physiology 2009 221 2 480 489 2-s2.0-70149125015 10.1002/jcp.21879
50. Hoeppner L. H., Secreto F. J., Razidlo D. F., Whitney T. J., Westendorf J. J., Lef1ΔN binds β -catenin and increases osteoblast activity and trabecular bone mass. The Journal of Biological Chemistry 2011 286 13 10950 10959 2-s2.0-79953231681 10.1074/jbc.M110.165100